View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 250 / Paclitaxel 80, Head and Neck Tumors, Cycle 2+
Protocol-ID: 708 V1.1 (Mini), CETU250/PACL80, Head and Neck Tumors, C2+Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 25.02.2020